| Literature DB >> 23656646 |
Christine M Laine1, Kyu Sang Joeng, Philippe M Campeau, Riku Kiviranta, Kati Tarkkonen, Monica Grover, James T Lu, Minna Pekkinen, Maija Wessman, Terhi J Heino, Vappu Nieminen-Pihala, Mira Aronen, Tero Laine, Heikki Kröger, William G Cole, Anna-Elina Lehesjoki, Lisette Nevarez, Deborah Krakow, Cynthia J R Curry, Daniel H Cohn, Richard A Gibbs, Brendan H Lee, Outi Mäkitie.
Abstract
This report identifies human skeletal diseases associated with mutations in WNT1. In 10 family members with dominantly inherited, early-onset osteoporosis, we identified a heterozygous missense mutation in WNT1, c.652T→G (p.Cys218Gly). In a separate family with 2 siblings affected by recessive osteogenesis imperfecta, we identified a homozygous nonsense mutation, c.884C→A, p.Ser295*. In vitro, aberrant forms of the WNT1 protein showed impaired capacity to induce canonical WNT signaling, their target genes, and mineralization. In mice, Wnt1 was clearly expressed in bone marrow, especially in B-cell lineage and hematopoietic progenitors; lineage tracing identified the expression of the gene in a subset of osteocytes, suggesting the presence of altered cross-talk in WNT signaling between the hematopoietic and osteoblastic lineage cells in these diseases.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23656646 PMCID: PMC3709450 DOI: 10.1056/NEJMoa1215458
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245